Uğur Şahin Made a Date for Tuberculosis and Malaria Vaccines

BioNTech founder Uğur Şahin talked about the importance of mRNA technology and gave dates for both tuberculosis and malaria vaccines. Saying that this technology is a potential solution for many diseases, the scientist announced that they received support from the Bill & Melinda Gates Foundation for AIDS and tuberculosis vaccines.

One of the two Turkish scientists who managed to develop the vaccine, which is the most powerful weapon for the coronavirus. Ugur Sahin, spoke to the French Le Monde. Making evaluations on the agenda, the scientist stated that mRNA technology is very important and has the potential to produce solutions for many diseases. “mRNA to many diseases could potentially be a remedy against.Using the expressions, Şahin also explained in which types of diseases this technology can be used.

According to the statements made by Uğur Şahin, with mRNA-based treatment methods, especially for infectious diseases, chronic ailments Cancer may also be history. Referring to the speed of mRNA technology, Prof. Uğur Şahin, the work done based on up-to-date datastates that in this way, more effective treatment methods can be developed.

“We receive support from the Bill & Melinda Gates Foundation”

Stating that their work is not limited to COVID-19, BioNTech founder, AIDS, tuberculosis and malaria He also says that they continue to work on vaccines. In fact, the Bill & Melinda Gates Foundation called Uğur Şahin’s team for AIDS and tuberculosis. is supporting. Explaining that the flu vaccine is on the way, Uğur Şahin used the following statements in his statement:

RELATED NEWS

BioNTech’s Founders Uğur Şahin and Özlem Türeci Suggested to Take Place in Euro Banknotes

We are working to develop vaccines against diseases such as AIDS, tuberculosis and malaria. To combat the first two diseases I mentioned We get support from the Bill & Melinda Gates Foundation. Currently, all projects are in the pre-clinical phase. In clinical development with our partner Pfizer for influenza vaccine Our work continues. Our goal is to begin clinical testing for malaria and tuberculosis by the end of 2022. In addition to these, we want to start the pre-clinical examination process for 10 different diseases…

Source :
https://www.sozcu.com.tr/2022/saglik/ugur-sahin-acikladi-bill-melinda-gates-vakfi-da-desteküldü-6868381/


source site-34